Jun 24 |
Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelzĀ® ProgramĀ with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin
|
Mar 27 |
Creative Medical Technology Holdings Provides Corporate Update
|
Mar 24 |
Creative Medical Technology Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|
Mar 7 |
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Mar 7 |
Creative Medical stock rallies for second day on FDA updates
|
Mar 7 |
Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
|
Mar 6 |
Creative Medical stock rallies 18% on FDA orphan drug designation
|
Mar 6 |
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
|